In the last trading session, 1.6 million shares of the Ocular Therapeutix Inc (NASDAQ:OCUL) were traded, and its beta was 1.48. Most recently the company’s share price was $9.61, and it changed around -$0.01 or -0.10% from the last close, which brings the market valuation of the company to $1.53B. OCUL currently trades at a discount to its 52-week high of $11.77, offering almost -22.48% off that amount. The share price’s 52-week low was $5.78, which indicates that the current value has risen by an impressive 39.85% since then. We note from Ocular Therapeutix Inc’s average daily trading volume that its 10-day average is 2.66 million shares, with the 3-month average coming to 2.14 million.
Ocular Therapeutix Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.08. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 6 rate it as Overweight. Among the rest, 0 recommended OCUL as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight.
Ocular Therapeutix Inc (NASDAQ:OCUL) trade information
Instantly OCUL has showed a red trend with a performance of -0.10% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 10.00 on recent trading dayincreased the stock’s daily price by 3.9%. The company’s shares are currently up 43.86% year-to-date, but still up 4.23% over the last five days. On the other hand, Ocular Therapeutix Inc (NASDAQ:OCUL) is 14.68% up in the 30-day period. We can see from the shorts that 14.42 million shares have been sold at a short interest cover period of 5.95 day(s).
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 49.42% from its current value. Analyst projections state that OCUL is forecast to be at a low of $19 and a high of $19.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 8.51%. Ocular Therapeutix Inc earnings are expected to increase by -17.19% in 2025, but the outlook is positive 4.11% per year for the next five years.
OCUL Dividends
Ocular Therapeutix Inc’s next quarterly earnings report is expected to be released on 2025-May-05.
Ocular Therapeutix Inc (NASDAQ:OCUL)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.82% of Ocular Therapeutix Inc shares, and 87.01% of them are in the hands of institutional investors. The stock currently has a share float of 90.46%. Ocular Therapeutix Inc stock is held by 256.0 institutions, with SUMMER ROAD LLC being the largest institutional investor. By 2024-06-30, it held 8.9767% of the shares, which is about 14.89 million shares worth $101.82 million.
VR ADVISER, LLC, with 7.6964% or 12.76 million shares worth $87.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
